JARID2 and central nervous system cancer: During the development of glioma cells, the decrease of JARID2 leads to a reduction in phosphorylation levels of protein kinase B (Akt) and phosphatidylinositol-3-kinase (PI3K), which inhibits the proliferation, migration, and invasion of glioma cells [34].